GTEX-YFC4
|
41-50
|
Female
|
GTEX-YFC4-2626 |
Thyroid gland
|
PAXgene |
1
|
2 pieces. Late stage Hashimoto's thyroiditis with regressive/fibrotic changes, prominent lymphoid follicles, rep ones delineated
|
Acceptable
|
 |
GTEX-YFCO
|
41-50
|
Male
|
GTEX-YFCO-0326 |
Thyroid gland
|
PAXgene |
0
|
2 pieces
|
Acceptable
|
 |
GTEX-YJ89
|
51-60
|
Male
|
GTEX-YJ89-0726 |
Thyroid gland
|
PAXgene |
1
|
2 pieces; patchy areas of lymphocytic or Hashimoto's thyroiditis
|
Acceptable
|
 |
GTEX-YJ8A
|
21-40
|
Male
|
GTEX-YJ8A-0226 |
Thyroid gland
|
PAXgene |
0
|
2 pieces; Hashimoto thyroiditis with marked lymphocytic infiltrate and atrophy
|
Acceptable
|
 |
GTEX-Z93S
|
51-60
|
Male
|
GTEX-Z93S-0526 |
Thyroid gland
|
PAXgene |
1
|
2 pieces, mulitple lymphoid aggregates consistent with Hashimoto's thyroiditis, rep. areas delineated; regressive/fibrotic areas present
|
Acceptable
|
 |
GTEX-Z9EW
|
41-50
|
Male
|
GTEX-Z9EW-0226 |
Thyroid gland
|
PAXgene |
1
|
2 pieces, micronodular goiter. Adherent fat on one , up to ~0.8mm
|
Acceptable
|
 |
GTEX-ZA64
|
21-40
|
Male
|
GTEX-ZA64-0426 |
Thyroid gland
|
PAXgene |
0
|
2 pieces, well-preserved
|
Acceptable
|
 |
GTEX-ZAB4
|
41-50
|
Male
|
GTEX-ZAB4-2026 |
Thyroid gland
|
PAXgene |
1
|
2 pieces. Severe fibrosis and lymphoid infiltrate with minimal thyroid tissue remaining; foci of squamous metaplasia. Most likely Riedel's thyroiditis; but cannot exclude Hashimoto's.
|
Unacceptable
|
 |
GTEX-ZAB5
|
51-60
|
Male
|
GTEX-ZAB5-0726 |
Thyroid gland
|
PAXgene |
0
|
2 pieces, ~5-10% attached fat and larger vessels, both pieces.
|
Acceptable
|
 |
GTEX-ZAJG
|
51-60
|
Female
|
GTEX-ZAJG-0726 |
Thyroid gland
|
PAXgene |
0
|
2 pieces, incidental 1mm cyst, delineated
|
Acceptable
|
 |
GTEX-ZAK1
|
51-60
|
Female
|
GTEX-ZAK1-0726 |
Thyroid gland
|
PAXgene |
1
|
2 pieces, incidental simple cysts
|
Acceptable
|
 |
GTEX-ZC5H
|
41-50
|
Female
|
GTEX-ZC5H-0626 |
Thyroid gland
|
PAXgene |
1
|
2 pieces, well preserved, minimal inflammation
|
Acceptable
|
 |
GTEX-ZDTS
|
61-70
|
Male
|
GTEX-ZDTS-0926 |
Thyroid gland
|
PAXgene |
1
|
2 pieces; 25% of 1 piece is fibroadipose and vascular tissue at one side (marked)
|
Acceptable
|
 |
GTEX-ZDTT
|
61-70
|
Male
|
GTEX-ZDTT-0626 |
Thyroid gland
|
PAXgene |
0
|
2 pieces, microscopic foci of papillary carcinoma, delineated.
|
Unacceptable
|
 |
GTEX-ZDXO
|
51-60
|
Male
|
GTEX-ZDXO-1726 |
Thyroid gland
|
PAXgene |
2
|
2 pieces, contaminant adipose tissue in one, delineated
|
Acceptable
|
 |
GTEX-ZDYS
|
51-60
|
Male
|
GTEX-ZDYS-0626 |
Thyroid gland
|
PAXgene |
1
|
2 pieces, some degenerative change
|
Acceptable
|
 |
GTEX-ZE7O
|
51-60
|
Female
|
GTEX-ZE7O-1126 |
Thyroid gland
|
PAXgene |
2
|
2 pieces; 1, 80% fat and piece of parathyroid (marked). Other piece, nodular with poor preservation.
|
Acceptable
|
 |
GTEX-ZE9C
|
61-70
|
Male
|
GTEX-ZE9C-0426 |
Thyroid gland
|
PAXgene |
1
|
2 pieces, no significant findings, minimal aderhent fat, delineated
|
Acceptable
|
 |
GTEX-ZEX8
|
51-60
|
Male
|
GTEX-ZEX8-0926 |
Thyroid gland
|
PAXgene |
1
|
2 pieces. Lymphoid nodules of Hashimoto thyroiditis. Foci of C-cell hyperplasia. This along with adrenal medullary hyperplasia raise probability of MEN IIB syndrome.
|
Acceptable
|
 |
GTEX-ZF28
|
61-70
|
Male
|
GTEX-ZF28-0826 |
Thyroid gland
|
PAXgene |
2
|
2 pieces. 1 mm adenomatoid nodule (marked)
|
Acceptable
|
 |
GTEX-ZF29
|
61-70
|
Female
|
GTEX-ZF29-0726 |
Thyroid gland
|
PAXgene |
0
|
2 pieces, ~10% of smaller piece is fat and vessels
|
Acceptable
|
 |
GTEX-ZF2S
|
51-60
|
Female
|
GTEX-ZF2S-0526 |
Thyroid gland
|
PAXgene |
1
|
2 pieces. Papillary carcinoma [3.3 mm]. Hashimoto thyroiditis, moderate degree.
|
Unacceptable
|
 |
GTEX-ZF3C
|
51-60
|
Female
|
GTEX-ZF3C-0826 |
Thyroid gland
|
PAXgene |
2
|
2 pieces, small focus of cartilage at edge of one piece
|
Acceptable
|
 |
GTEX-ZG7Y
|
51-60
|
Male
|
GTEX-ZG7Y-0226 |
Thyroid gland
|
PAXgene |
1
|
2 pieces, no significant findings
|
Acceptable
|
 |
GTEX-ZGAY
|
41-50
|
Female
|
GTEX-ZGAY-1026 |
Thyroid gland
|
PAXgene |
1
|
2 pieces, 2mm colloid cyst, encircled. Mild generalized goiter with regressive changes.
|
Acceptable
|
 |